CICI
GSK icon

Capital Investment Counsel Inc’s GSK GSK Stock Holding History

Capital Investment Counsel Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,160
Closed -$278K – 145
2014
Q2 		$278K Sell
4,160
-640
-13% -$43.3K 0.12% 134
2014
Q1 		$321K Buy
4,800
+80
+2% +$5.41K 0.14% 123
2013
Q4 		$315K Hold
4,720
– – 0.14% 120
2013
Q3 		$296K Sell
4,720
-160
-3% -$10.3K 0.15% 117
2013
Q2 		$305K Buy
+4,880
New +$310K 0.16% 117

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Investment Counsel Inc's GSK Position: Q3 2014 in Review

Capital Investment Counsel Inc sold out of GSK (GSK) in Q3 2014, closing a stake of 4,160 shares — an estimated $278K sold.

Capital Investment Counsel Inc first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $321K in Q1 2014. 702 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Capital Investment Counsel Inc reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Capital Investment Counsel Inc sold 4,160 GSK shares in Q3 2014, an estimated $278K.
  • Capital Investment Counsel Inc first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Capital Investment Counsel Inc's GSK position peaked at $321K in Q1 2014.
  • 702 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Capital Investment Counsel Inc's 13F filing for Q3 2014, filed 6 Nov 2014.